LITE STRATEGY INC (LITS) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:LITS • US55279B3015

1.06 USD
-0.09 (-7.83%)
At close: Feb 4, 2026
1.04 USD
-0.02 (-1.89%)
After Hours: 2/4/2026, 5:09:39 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
LITS revenue by date.LITS revenue by date.
40.7M
16.95%
48.82M
19.95%
65.297M
33.75%

-100.00%
25.5M25.5M
EBITDA
YoY % growth
LITS ebitda by date.LITS ebitda by date.
-75.15M
-24.98%
-36.37M
51.60%
25.824M
171.00%
N/A
-166.17%
N/AN/A
EBIT
YoY % growth
LITS ebit by date.LITS ebit by date.
-75.48M
-24.93%
-36.76M
51.30%
25.441M
169.21%
-46.447M
-168.61%
-29.939M
-71.52%
-33.288M
-11.18%
Operating Margin
LITS operating margin by date.LITS operating margin by date.
-185.45%-75.30%38.96%N/A-117.41%-130.54%
EPS
YoY % growth
LITS eps by date.LITS eps by date.
-7.00
22.22%
-4.63
33.86%
2.67
157.67%
-6.41
-339.91%
-3.78
40.92%
-1.59
57.95%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26
EPS
Q2Q % growth
N/A
Revenue
Q2Q % growth
N/A
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-2.76
-82.78%
-1.46-1.30-88.56%
Q3 2024
Q2Q % growth
-1.37
40.95%
-1.550.1811.64%
Q2 2024
Q2Q % growth
-1.66
-203.75%
-1.35-0.31-22.83%
Q1 2024
Q2Q % growth
8.46
452.50%
-2.1610.62491.23%
Q4 2023
Q2Q % growth
-1.51
37.08%
-2.460.9538.70%
Q3 2023
Q2Q % growth
-2.32
-65.71%
-2.920.6020.66%
Q2 2023
Q2Q % growth
1.60
260.00%
-3.064.66152.29%
Q1 2023
Q2Q % growth
-2.40
-9.09%
-2.920.5217.92%
Q4 2022
Q2Q % growth
-2.40
-140.00%
-3.791.3936.65%
Q3 2022
Q2Q % growth
-1.40
75.00%
-3.722.3262.40%
Q2 2022
Q2Q % growth
-1.00
50.00%
-4.133.1375.79%
Q1 2022
Q2Q % growth
-2.20
-450.00%
-2.570.3714.41%
Q4 2021
Q2Q % growth
-1.00
73.68%
-3.572.5771.99%
Q3 2021
Q2Q % growth
-5.60
-600.00%
-3.32-2.28-68.93%
Q2 2021
Q2Q % growth
-2.00
61.54%
-2.710.7126.21%
Q1 2021
Q2Q % growth
-0.40
50.00%
-1.671.2776.09%
Q4 2020
Q2Q % growth
-3.80 4.39-8.19-186.64%
Q3 2020
Q2Q % growth
-0.80 -2.802.0071.40%
Q2 2020
Q2Q % growth
-5.20 -3.43-1.77-51.43%
Q1 2020
Q2Q % growth
-0.80 -3.472.6776.93%
LITS Yearly EPS VS EstimatesLITS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth

-100.00%
%
Q3 2024
Q2Q % growth

-100.00%
38.25K-38.25K-100.00%
Q2 2024
Q2Q % growth

-100.00%
102K-102K-100.00%
Q1 2024
Q2Q % growth
65.3M
648.00%
65.3M%
Q4 2023
Q2Q % growth
1.46M
-87.20%
949.62K510.38K53.75%
Q3 2023
Q2Q % growth
5.89M
-39.22%
471.577K5.418M1,149.00%
Q2 2023
Q2Q % growth
32.74M
176.75%
5.399M27.341M506.41%
Q1 2023
Q2Q % growth
8.73M
12.50%
6.015M2.715M45.14%
Q4 2022
Q2Q % growth
11.41M
53.15%
4.865M6.545M134.53%
Q3 2022
Q2Q % growth
9.69M
19.48%
3.508M6.182M176.23%
Q2 2022
Q2Q % growth
11.83M
-6.11%
3.328M8.502M255.47%
Q1 2022
Q2Q % growth
7.76M
16.87%
12.509M-4.749M-37.96%
Q4 2021
Q2Q % growth
7.45M
-69.40%
3.643M3.807M104.50%
Q3 2021
Q2Q % growth
8.11M
554.03%
5.52M2.59M46.92%
Q2 2021
Q2Q % growth
12.6M
1,147.52%
3.909M8.691M222.33%
Q1 2021
Q2Q % growth
6.64M
472.41%
4.371M2.269M51.91%
Q4 2020
Q2Q % growth
24.35M 45.976M-21.626M-47.04%
Q3 2020
Q2Q % growth
1.24M 1.61M-370K-22.98%
Q2 2020
Q2Q % growth
1.01M 1.603M-593K-36.99%
Q1 2020
Q2Q % growth
1.16M 1.356M-196K-14.45%
LITS Yearly Revenue VS EstimatesLITS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%